DGAP-News: Announcement: 4SC to host conference call on 8 August 2013 to present half year results 2

DGAP-News: Announcement: 4SC to host conference call on 8 August 2013 to present half year results 2013

ID: 284005

(firmenpresse) - DGAP-News: 4SC AG / Key word(s): Miscellaneous
Announcement: 4SC to host conference call on 8 August 2013 to present
half year results 2013

01.08.2013 / 16:04

---------------------------------------------------------------------

Announcement

4SC to host conference call on 8 August 2013 to present half year results
2013

Planegg-Martinsried, Germany, 1 August 2013 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will announce second
quarter results 2013 of the 4SC Group and publish the company's half year
report 2013 on 8 August 2013. On this day the Management Board of 4SC AG
will host a conference call at 3pm CEST (9am EDT) to inform about the
consolidated financial statements and important developments in the
reporting period and beyond.

Investors, financial analysts, and journalists participating in the
conference call can access via the following telephone numbers:

Date: 8 August 2013
Time: 3pm CEDT (9am EDT)
Dial-in numbers:
+49-6958-999-0808 (Germany)
+44-207-153-2027 (UK)
+1-480-629-9870 (USA)
+49-6958-999-0808 (other countries)
Conference-ID: 4632901

After the conference call a replay will be available in the section
'Investors' / 'Events&Presentations' / 'Conference Calls&Webcasts' of
the website www.4sc.com.

Ends

About 4SC

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in




various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
leading pharmaceutical and biotech companies. Founded in 1997, 4SC had 83
employees at 30 June 2013. 4SC AG has been listed on the Prime Standard of
the Frankfurt Stock Exchange since December 2005.

Legal Note

This document may contain projections or estimates relating to plans and
objectives relating to our future operations, products, or services; future
financial results; or assumptions underlying or relating to any such
statements; each of which constitutes a forward-looking statement subject
to risks and uncertainties, many of which are beyond our control. Actual
results could differ materially, depending on a number of factors.

For more information please visit www.4sc.com or contact:

4SC AG
Jochen Orlowski, Corporate Communications&Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366

MC Services
Raimund Gabriel
raimund.gabriel(at)mc-services.eu , Tel.: +49-89-2102-2830

The Trout Group
Chad Rubin
Crubin(at)troutgroup.com, Tel.: +1-646-378-2947


End of Corporate News

---------------------------------------------------------------------

01.08.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public(at)4sc.com
Internet: www.4sc.de
ISIN: DE0005753818
WKN: 575381
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
223911 01.08.2013


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  DGAP-News: RHÖN-KLINIKUM AG: A shareholder has filed legal action for annulment and declaratory relief against a resolution passed by the Annual General Meeting DGAP-News: All for One Steeb AG: 9-Month Results for the Financial Year 2012/13
Bereitgestellt von Benutzer: EquityStory
Datum: 01.08.2013 - 16:04 Uhr
Sprache: Deutsch
News-ID 284005
Anzahl Zeichen: 5637

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 271 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DGAP-News: Announcement: 4SC to host conference call on 8 August 2013 to present half year results 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

4SC AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von 4SC AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z